• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, September 24, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

The Journal of Nuclear Medicine impact factor increases by 12 percent

Bioengineer by Bioengineer
July 18, 2018
in Cancer
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

RESTON, VA – The Journal of Nuclear Medicine (JNM)–the flagship publication of the Society of Nuclear Medicine and Molecular Imaging (SNMMI)–has again been ranked among the top medical imaging journals worldwide, according to new data just released in the 2017 Journal Citation ReportsĀ© published by Clarivate Analytics.

JNM's impact factor increased 12%, from 6.646 (2016) to 7.439 (2017), and the journal ranked fifth in impact factor of the 128 journals included in the medical imaging category. JNM's five-year impact factor is 6.893, up from 6.459 the previous year. Citations to the journal increased from 24,977 to 27,101, and JNM's article influence score is 1.852.

"JNM's increasing impact factor demonstrates the journal's influential role in molecular imaging, and we are honored that it is the journal of choice for many distinguished researchers," said Editor-in-Chief Johannes Czernin, MD, professor of molecular and medical pharmacology and chief of the Ahmanson Translational Imaging Division at the UCLA David Geffen School of Medicine, Los Angeles, California. "Among nuclear medicine journals, JNM continues to have the highest number of citations, the highest average 5-year impact factor, the highest number of citable articles, and the highest influence score."

He pointed out, "As this impact factor is based on 2016 data, all the credit for this increase goes to JNM Immediate Past Editor Dominique Delbeke, MD, PhD, at Vanderbilt University Medical Center in Nashville, Tennessee. We are continuing to build on her success, focusing on providing the highest quality in basic, translational and clinical sciences."

The Institute for Scientific Information (ISI), now based in Clarivate Analytics' Scientific and Academic Research Group, measures a journal's impact–or significance–based on the number of article citations compared to the total number of articles published. The impact factor–a quantitative measure of the frequency with which an article in a journal is cited–is used to gauge the overall influence of a journal within scientific, professional and academic communities. For more than 50 years, ISI has provided a systematic and objective way for librarians, researchers and other decision-makers to measure influence in the global research community.

The Journal Citation Report also publishes an immediacy index for journals as an indicator of the speed with which citations to a specific journal appear in published literature. JNM's immediacy index for 2017 is 2.474, up from 1.574.

###

The Journal of Nuclear Medicine is available online at http://jnm.snmjournals.org. Print copies are available for purchase at $58 per copy (plus shipping and handling). To order a copy, contact the SNMMI Subscription Services at [email protected] or telephone 1-800-513-6853. A 2017 subscription to the journal online–including full-color design, full access to archives, and access to articles online ahead of print–costs $383 for individuals and $877 for institutions.

ABOUT THE SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an international scientific and medical organization dedicated to advancing nuclear medicine and molecular imaging, vital elements of precision medicine that allow diagnosis and treatment to be tailored to individual patients in order to achieve the best possible outcomes.

SNMMI's more than 16,000 members set the standard for molecular imaging and nuclear medicine practice by creating guidelines, sharing information through journals and meetings and leading advocacy on key issues that affect molecular imaging and therapy research and practice. For more information, visit http://www.snmmi.org.

Media Contact

Laurie F Callahan
[email protected]
@SNM_MI

http://www.snm.org

http://www.snmmi.org/NewsPublications/NewsDetail.aspx?ItemNumber=29584

Share12Tweet8Share2ShareShareShare2

Related Posts

Study Suggests Fat Distribution May Impact Cancer Risk

September 24, 2025

Sylvester Joins $16M National Initiative on AI for Breast Cancer Screening

September 24, 2025

Fish Oil Supplements May Be Ineffective for Certain Cancer Patients, Study Finds

September 23, 2025

NBL1 Identified as a Critical Factor in Ovarian Cancer Metastasis

September 23, 2025
Please login to join discussion

POPULAR NEWS

  • Physicists Develop Visible Time Crystal for the First Time

    Physicists Develop Visible Time Crystal for the First Time

    69 shares
    Share 28 Tweet 17
  • Tailored Gene-Editing Technology Emerges as a Promising Treatment for Fatal Pediatric Diseases

    50 shares
    Share 20 Tweet 13
  • Scientists Achieve Ambient-Temperature Light-Induced Heterolytic Hydrogen Dissociation

    49 shares
    Share 20 Tweet 12
  • Rapid Spread of Drug-Resistant Fungus Candidozyma auris in European Hospitals Prompts Urgent Warning from ECDC

    48 shares
    Share 19 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Electrolytes Impact Graphene Exfoliation and Supercapacitor Efficiency

Trends in Breast Cancer Screening for Older Women

Long-Term Durability of Valoctocogene Roxaparvovec in Hemophilia A

  • Contact Us

Bioengineer.org Ā© Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org Ā© Copyright 2023 All Rights Reserved.